Enesi Pharma and Sementis Sign R&D Collaboration Focused on Needle-free Solid Dose Vaccines for Peanut Allergy and Chikungunya/Zika Infection

OXFORD, England and MELBOURNE, Australia, November 5, 2018 /PRNewswire/ -- Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, and Sementis, a biotechnology company developing innovative vaccine candidates for the...

from PR Newswire: //https://ift.tt/2ALzpAi